In 2023, the import of streptomycins to India stood at an undisclosed value, but the projected trends from 2024 onward show a steady increase. The forecast from 2024 to 2028 indicates a gradual rise, starting at $19.197 million USD in 2024 and reaching $22.07 million USD by 2028. This corresponds to a year-on-year growth rate ranging mostly between 3.7% and 4%. Anticipated trends suggest an average annual growth (CAGR) of approximately 4.29% over these five years, reflecting consistent demand and import growth dynamics.

Future trends to watch for include:

The impact of domestic production advancements on import needs
Potential regulatory changes concerning pharmaceutical imports
Fluctuations in global prices due to supply chain dynamics
Developments in alternative antibacterial therapies reducing dependency on streptomycins